These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26003159)

  • 1. Evaluation of a pharmacist-performed tuberculosis testing initiative in New Mexico.
    Jakeman B; Gross B; Fortune D; Babb S; Tinker D; Bachyrycz A
    J Am Pharm Assoc (2003); 2015; 55(3):307-12. PubMed ID: 26003159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist perceptions of the New Mexico pharmacist-performed tuberculosis testing program.
    Logothetis SJ; Borrego ME; Roberts MH; Bachyrycz A; Timmins GS; Jakeman B
    J Am Pharm Assoc (2003); 2018; 58(6):647-651. PubMed ID: 30274884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculin skin testing by pharmacists in a grocery store setting.
    Hecox N
    J Am Pharm Assoc (2003); 2008; 48(1):86-91. PubMed ID: 18192135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient perceptions of a tuberculosis testing program provided in the community pharmacy setting.
    Jakeman B; Logothetis SJ; Saba M; Anderson D; Acosta JM; Borrego ME; Roberts MH; Bachyrycz A; Fortune D; Burgos M
    Public Health; 2020 Apr; 181():135-140. PubMed ID: 32014641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors associated with latent tuberculosis infection in Mexican American children.
    Young J; O'Connor ME
    Pediatrics; 2005 Jun; 115(6):e647-53. PubMed ID: 15930191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist-provided rapid HIV testing in two community pharmacies.
    Darin KM; Klepser ME; Klepser DE; Klepser SA; Reeves A; Young M; Scarsi KK
    J Am Pharm Assoc (2003); 2015; 55(1):81-8. PubMed ID: 25415222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacists' perspectives on HIV testing in community pharmacies.
    Ryder PT; Meyerson BE; Coy KC; von Hippel CD
    J Am Pharm Assoc (2003); 2013; 53(6):595-600. PubMed ID: 24091415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking cessation and its predictors: results from a community-based pharmacy tobacco cessation program in New Mexico.
    Khan N; Anderson JR; Du J; Tinker D; Bachyrycz AM; Namdar R
    Ann Pharmacother; 2012 Sep; 46(9):1198-204. PubMed ID: 22911338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a school-based tuberculosis-screening program and associate investigation targeting recently immigrated children in a low-burden country.
    Brassard P; Steensma C; Cadieux L; Lands LC
    Pediatrics; 2006 Feb; 117(2):e148-56. PubMed ID: 16452324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent of services provided by pharmacists in the Iowa Medicaid Pharmaceutical Case Management program.
    Carter BL; Chrischilles EA; Scholz D; Hayase N; Bell N
    J Am Pharm Assoc (Wash); 2003; 43(1):24-33. PubMed ID: 12585748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suspected tuberculosis case detection and referral in private pharmacies in Viet Nam.
    Vu DH; van Rein N; Cobelens FG; Nguyen TT; Le VH; Brouwers JR
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1625-9. PubMed ID: 23131260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient attitudes regarding pharmacist-administered memory screening in community pharmacies.
    Breslow RM
    J Am Pharm Assoc (2003); 2013; 53(6):648-51. PubMed ID: 24185433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency contraception availability in New Mexico: impact of direct pharmacy access.
    Ogburn JA; Espey E; Benjamin A
    J Am Pharm Assoc (2003); 2008; 48(3):388-92. PubMed ID: 18595824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on prescribing hormonal contraception among rural New Mexican pharmacists.
    Herman A; McCauley G; Thaxton L; Borrego M; Sussman AL; Espey E
    J Am Pharm Assoc (2003); 2020; 60(5):e57-e63. PubMed ID: 32249171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy.
    Gubbins PO; Klepser ME; Dering-Anderson AM; Bauer KA; Darin KM; Klepser S; Matthias KR; Scarsi K
    J Am Pharm Assoc (2003); 2014; 54(2):163-71. PubMed ID: 24632931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
    Skelton JB; ;
    J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist testers in multidisciplinary health care team expand HIV point-of-care testing program.
    Sherman EM; Elrod S; Allen D; Eckardt P
    J Pharm Pract; 2014 Dec; 27(6):578-81. PubMed ID: 24326407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation.
    Wells KM; Thornley T; Boyd MJ; Boardman HF
    Res Social Adm Pharm; 2014; 10(1):58-71. PubMed ID: 23608701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient satisfaction with pharmacist-administered Mantoux tuberculin skin test in a community-based pharmacy setting.
    Goode JV; Upshur R; Grimes MB; Nadpara P
    J Am Pharm Assoc (2003); 2019; 59(4S):S77-S80.e2. PubMed ID: 31203013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.